Stay updated on Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedLung cancer as the condition and related topics such as MedlinePlus Genetics were removed from the page, reducing essential context for the trial.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded related topics Lung cancer and MedlinePlus Genetics, and updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedMinor UI and metadata tweaks include a glossary display label, the 'Last Update Submitted that Met QC Criteria' header, and new page footer items 'No FEAR Act Data' and 'Revision: v3.4.0', with removal of related-topic terms like 'Lung cancer' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check35 days agoChange DetectedNew update dates were added to the Study Record Dates: 2026-01-20, 2025-12-30, and 2025-12. Older entries (2024-11-12, 2024-10-17, 2024-10) were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision indicates a maintenance metadata update (Revision: v3.3.4) replacing v3.3.3, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Small Cell Lung Cancer Clinical Trial page.